Obesity; Endocrine Clinical Trial
Official title:
Lipolysis of Visceral Reserve Fat Using Tecar Therapy: Anthropometric, Biochemical and NMR Imaging Study.
NCT number | NCT06377358 |
Other study ID # | CEEAH CA31 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 9, 2022 |
Est. completion date | June 22, 2023 |
Verified date | April 2024 |
Source | CAPENERGY MEDICAL, SL |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Scope of this study is to assess the visceral and subcutaneous fat loss in patients having Tecar (Radiofrequency) Therapy and its effects on other anthropometric variables, adipokines and inflammation. 20 obese patients will be treated with Tecar Therapy (Radiofrequency). Each patient will have 4 active, automatic plates placed on the abdomen (200 cm2 per plate), two on the right side of the midline and two on the left side. Energy will be applied for 50 minutes, controlling the temperature. Subsequently, 15 minutes of Capacitive and Resistive manual electrodes will be applied to the abdomen, simultaneously, 20 minutes of Lymphatic Drainage placing one active plate in the foot and the other in the lumbo-dorsal area. Patients will be informed that they will only feel comfortable warmth. Five sessions will be applied from Monday to Friday resting Saturday and Sunday, for 2 weeks. Total 10 sessions. Subcutaneous and visceral fat will be measured by MRI. Anthropometric variables (Body Mass Index, Waist to Hip ratio and skinfold) will be also measured. Metabolic and inflammatory effects of the RF treatment will be evaluated measuring adipokines (Leptin, adiponectin and resistin) as well as citokines (IL-6, TNF-a and C reactive Protein). Results will be analyzed using the SPSS statistics package. A Kolmogorov-Smirnov test will be applied, if the data behaves normally, parametric tests will be applied. If not, non-parametric tests will be performed. The differences between proportions will be analyzed using Fischer's exact test. The differences between the medians will be assessed using the Student's t-test for paired samples and independent samples.
Status | Completed |
Enrollment | 20 |
Est. completion date | June 22, 2023 |
Est. primary completion date | July 25, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 80 Years |
Eligibility | Inclusion criteria: - Men and women. - Age from 20 to 80 years. - Waist circumference > 102 cm in men and > 88 cm in women. - BMI > 25 Kg/mt2. - Visceral fat quantification > 9 (on a scale of 20). Exclusion Criteria: - Refusal to sign the informed consent. - Pregnancy. - Patients with metal prostheses. - Presence of active infection. - Patients with oncological history with chemotherapy treatments or radiotherapy. - Presence of diabetes. - Presence of metabolic disease. - Presence of arterial hypertension. |
Country | Name | City | State |
---|---|---|---|
Spain | Inneo Terapia Despi | Barcelona |
Lead Sponsor | Collaborator |
---|---|
CAPENERGY MEDICAL, SL | Alfonso X El Sabio University, University of Malaga |
Spain,
Alexiades-Armenakas M, Dover JS, Arndt KA. Unipolar radiofrequency treatment to improve the appearance of cellulite. J Cosmet Laser Ther. 2008 Sep;10(3):148-53. doi: 10.1080/14764170802279651. — View Citation
Araki E, Oyadomari S, Mori M. Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med (Maywood). 2003 Nov;228(10):1213-7. doi: 10.1177/153537020322801018. — View Citation
Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El-Sohemy A, Karmali M. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes. 2010 May 26;3:173-86. doi: 10.2147/dmsott.s9089. — View Citation
Belenky I, Margulis A, Elman M, Bar-Yosef U, Paun SD. Exploring channeling optimized radiofrequency energy: a review of radiofrequency history and applications in esthetic fields. Adv Ther. 2012 Mar;29(3):249-66. doi: 10.1007/s12325-012-0004-1. Epub 2012 Feb 29. — View Citation
Bjorntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990 Jul-Aug;10(4):493-6. No abstract available. — View Citation
Chang SL, Huang YL, Lee MC, Chang CH, Lin YF, Cheng CY, Hu S. Long-term follow-up for noninvasive body contouring treatment in Asians. Lasers Med Sci. 2016 Feb;31(2):283-7. doi: 10.1007/s10103-015-1852-0. Epub 2015 Dec 29. — View Citation
Duarte FO, Sene-Fiorese M, de Aquino Junior AE, da Silveira Campos RM, Masquio DC, Tock L, Garcia de Oliveira Duarte AC, Damaso AR, Bagnato VS, Parizotto NA. Can low-level laser therapy (LLLT) associated with an aerobic plus resistance training change the cardiometabolic risk in obese women? A placebo-controlled clinical trial. J Photochem Photobiol B. 2015 Dec;153:103-10. doi: 10.1016/j.jphotobiol.2015.08.026. Epub 2015 Sep 2. — View Citation
Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017 Jun;13(4):851-863. doi: 10.5114/aoms.2016.58928. Epub 2016 Mar 31. — View Citation
Eloi JC, Epifanio M, de Goncalves MM, Pellicioli A, Vieira PF, Dias HB, Bruscato N, Soder RB, Santana JC, Mouzaki M, Baldisserotto M. Quantification of Abdominal Fat in Obese and Healthy Adolescents Using 3 Tesla Magnetic Resonance Imaging and Free Software for Image Analysis. PLoS One. 2017 Jan 27;12(1):e0167625. doi: 10.1371/journal.pone.0167625. eCollection 2017. — View Citation
Fritz K, Salavastru C, Gyurova M. Clinical evaluation of simultaneously applied monopolar radiofrequency and targeted pressure energy as a new method for noninvasive treatment of cellulite in postpubertal women. J Cosmet Dermatol. 2018 Jun;17(3):361-364. doi: 10.1111/jocd.12525. Epub 2018 Mar 9. — View Citation
Gabai VL, Meriin AB, Yaglom JA, Wei JY, Mosser DD, Sherman MY. Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation. HSP72 alleviates the stewss-induced inhibition of JNK dephosphorylation. J Biol Chem. 2000 Dec 1;275(48):38088-94. doi: 10.1074/jbc.M006632200. — View Citation
Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002 Apr;75(4):683-8. doi: 10.1093/ajcn/75.4.683. — View Citation
Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004 Mar;79(3):379-84. doi: 10.1093/ajcn/79.3.379. — View Citation
Kaplan H, Gat A. Clinical and histopathological results following TriPollar radiofrequency skin treatments. J Cosmet Laser Ther. 2009 Jun;11(2):78-84. doi: 10.1080/14764170902846227. — View Citation
Klopfenstein BJ, Kim MS, Krisky CM, Szumowski J, Rooney WD, Purnell JQ. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol. 2012 Oct;85(1018):e826-30. doi: 10.1259/bjr/57987644. Epub 2012 Apr 18. — View Citation
Kondo T, Sasaki K, Matsuyama R, Morino-Koga S, Adachi H, Suico MA, Kawashima J, Motoshima H, Furukawa N, Kai H, Araki E. Hyperthermia with mild electrical stimulation protects pancreatic beta-cells from cell stresses and apoptosis. Diabetes. 2012 Apr;61(4):838-47. doi: 10.2337/db11-1098. Epub 2012 Feb 23. — View Citation
Maffeis C, Corciulo N, Livieri C, Rabbone I, Trifiro G, Falorni A, Guerraggio L, Peverelli P, Cuccarolo G, Bergamaschi G, Di Pietro M, Grezzani A. Waist circumference as a predictor of cardiovascular and metabolic risk factors in obese girls. Eur J Clin Nutr. 2003 Apr;57(4):566-72. doi: 10.1038/sj.ejcn.1601573. — View Citation
Mazzoni D, Lin MJ, Dubin DP, Khorasani H. Review of non-invasive body contouring devices for fat reduction, skin tightening and muscle definition. Australas J Dermatol. 2019 Nov;60(4):278-283. doi: 10.1111/ajd.13090. Epub 2019 Jun 6. — View Citation
Minami Y, Hohfeld J, Ohtsuka K, Hartl FU. Regulation of the heat-shock protein 70 reaction cycle by the mammalian DnaJ homolog, Hsp40. J Biol Chem. 1996 Aug 9;271(32):19617-24. doi: 10.1074/jbc.271.32.19617. — View Citation
Moreno LA, Pineda I, Rodriguez G, Fleta J, Sarria A, Bueno M. Waist circumference for the screening of the metabolic syndrome in children. Acta Paediatr. 2002;91(12):1307-12. doi: 10.1080/08035250216112. — View Citation
Morino S, Suico MA, Kondo T, Sekimoto E, Yano S, Matsuda T, Matsuno T, Shuto T, Araki E, Kai H. Mild electrical stimulation increases ubiquitinated proteins and Hsp72 in A549 cells via attenuation of proteasomal degradation. J Pharmacol Sci. 2008 Oct;108(2):222-6. doi: 10.1254/jphs.08180sc. Epub 2008 Oct 10. — View Citation
Mulholland RS, Paul MD, Chalfoun C. Noninvasive body contouring with radiofrequency, ultrasound, cryolipolysis, and low-level laser therapy. Clin Plast Surg. 2011 Jul;38(3):503-20, vii-iii. doi: 10.1016/j.cps.2011.05.002. — View Citation
Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Bjorntorp P, Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985 Oct;34(10):1055-8. doi: 10.2337/diab.34.10.1055. — View Citation
Park HS, Lee JS, Huh SH, Seo JS, Choi EJ. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J. 2001 Feb 1;20(3):446-56. doi: 10.1093/emboj/20.3.446. — View Citation
Pereira JX, Cavalcante Y, Wanzeler de Oliveira R. The role of inflammation in adipocytolytic nonsurgical esthetic procedures for body contouring. Clin Cosmet Investig Dermatol. 2017 Feb 23;10:57-66. doi: 10.2147/CCID.S125580. eCollection 2017. — View Citation
Pinto H. Local fat treatments: classification proposal. Adipocyte. 2015 Jun 26;5(1):22-6. doi: 10.1080/21623945.2015.1066534. eCollection 2016 Jan-Mar. — View Citation
Pumprla J, Howorka K, Kolackova Z, Sovova E. Non-contact radiofrequency-induced reduction of subcutaneous abdominal fat correlates with initial cardiovascular autonomic balance and fat tissue hormones: safety analysis. F1000Res. 2015 Feb 20;4:49. doi: 10.12688/f1000research.5708.1. eCollection 2015. — View Citation
Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA. 1998 Dec 2;280(21):1843-8. doi: 10.1001/jama.280.21.1843. — View Citation
Ryden M, Arner P. Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels. Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1782-1787. doi: 10.1161/ATVBAHA.117.309759. Epub 2017 Jun 29. — View Citation
Sharp FR, Massa SM, Swanson RA. Heat-shock protein protection. Trends Neurosci. 1999 Mar;22(3):97-9. doi: 10.1016/s0166-2236(98)01392-7. No abstract available. — View Citation
Shinohara T, Takahashi N, Ooie T, Hara M, Shigematsu S, Nakagawa M, Yonemochi H, Saikawa T, Yoshimatsu H. Phosphatidylinositol 3-kinase-dependent activation of akt, an essential signal for hyperthermia-induced heat-shock protein 72, is attenuated in streptozotocin-induced diabetic heart. Diabetes. 2006 May;55(5):1307-15. doi: 10.2337/db05-0266. — View Citation
Sugawara J, Kou S, Kokubo K, Kuroda A, Hashizume Y, Kobayashi S, Maegawa J, Satake T. Application for lower facial fat reduction and tightening by static type monopolar 1-MHz radio frequency for body contouring. Lasers Surg Med. 2017 Oct;49(8):750-755. doi: 10.1002/lsm.22676. Epub 2017 Apr 22. — View Citation
van der Lugt C, Romero C, Ancona D, Al-Zarouni M, Perera J, Trelles MA. A multicenter study of cellulite treatment with a variable emission radio frequency system. Dermatol Ther. 2009 Jan-Feb;22(1):74-84. doi: 10.1111/j.1529-8019.2008.01218.x. — View Citation
World Health Organization. Waist circumference and waist-hip ratio - Report of a WHO expert consultation, Geneva, 8-11 December 2008
Wu B, Hunt C, Morimoto R. Structure and expression of the human gene encoding major heat shock protein HSP70. Mol Cell Biol. 1985 Feb;5(2):330-41. doi: 10.1128/mcb.5.2.330-341.1985. — View Citation
* Note: There are 35 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visceral fat loss (cm3) | Measurement of Visceral fat loss (cm3) after Tecar Therapy treatment. | 3 months | |
Primary | Visceral fat loss (g) | Measurement of Visceral fat loss (g) after Tecar Therapy treatment. | 3 months | |
Primary | Subcutaneous fat loss (cm3) | Measurement of subcutaneous fat loss (cm3) after Tecar Therapy treatment. | 3 months | |
Primary | Subcutaneous fat loss (g) | Measurement of subcutaneous fat loss (g) after Tecar Therapy treatment. | 3 months | |
Primary | Tumor Necrosis Factor alfa | Chanches in serum/plasma levels of Tumor Necrosis Factor alfa (pg/mL) after Tecar Therapy treatment. | 2 months | |
Primary | Interleukin 6 levels | Chanches in serum/plasma levels of Interleukin 6 (pg/mL) after Tecar Therapy treatment. | 2 months | |
Primary | C reactive Protein levels | Chanches in serum/plasma C reactive Protein (mg/L) after Tecar Therapy treatment. | 2 months | |
Primary | Leptin levels | Chanches in serum/plasma levels of leptin after Tecar Therapy treatment. | 2 months | |
Primary | Adiponectin levels | Chanches in serum/plasma levels of adiponectin after Tecar Therapy treatment. | 2 months | |
Primary | Resistin levels | Chanches in serum/plasma levels of resistin after Tecar Therapy treatment. | 2 months | |
Primary | Total cholesterol changes | Measurement of serum total cholesterol (mg/dL) after Tecar Therapy treatment. | 3 months | |
Primary | Total triglycerides changes | Measurement of serum total triglycerides (mg/dL) after Tecar Therapy treatment. | 3 months | |
Primary | LDL Cholesterol changes | Measurement of serum LDL Cholesterol (mg/dL) after Tecar Therapy treatment. | 3 months | |
Primary | HDL Cholesterol changes | Measurement of serum HDL Cholesterol (mg/dL) after Tecar Therapy treatment. | 3 months | |
Primary | Glucose | Measurement of serum HDL Cholesterol (mg/dL) after Tecar Therapy treatment. | 3 months | |
Secondary | Body Mass Index loss | Measurement of Body Mass Index loss (Kg/m2) after Tecar Therapy treatment. | 3 months | |
Secondary | Waist to Hip Index loss | Measurement of the Waist to Hip Index loss (cm) after Tecar Therapy treatment. | 3 months | |
Secondary | Skinfold Thickness (cm) | Measurement of the Skinfold Thickness (cm) after Tecar Therapy treatment. | 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
Completed |
NCT03638843 -
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy - Part 2
|
N/A | |
Active, not recruiting |
NCT06461806 -
Effect of Protein Source During Ketogenic Weight Loss Intervention
|
N/A | |
Completed |
NCT03239782 -
The "Metabolically-obese Normal-weight" Phenotype and Its Reversal by Calorie Restriction
|
N/A | |
Recruiting |
NCT04100616 -
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
|
||
Recruiting |
NCT03008525 -
Vitamin D and Its Metabolites Quantification in Adipose Tissues of Obese and Non-obese Patients.
|
N/A | |
Completed |
NCT03526263 -
Endoscopic Gastric Mucosal Devitalization (GMD) as a Primary Obesity Therapy
|
N/A | |
Recruiting |
NCT05322551 -
Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery
|
||
Completed |
NCT03527446 -
Acute and Chronic Metabolic Flexibility in Individuals Living With Obesity: The i-FLEX Study
|
N/A | |
Completed |
NCT06357273 -
The Effect of White Tea Consumption on Obesity
|
||
Recruiting |
NCT04573998 -
Study on the Mechanism of lcn2 in Obesity
|
||
Recruiting |
NCT05676229 -
Probiotic Blend in Reducing Anthropometric Measurements in Obese Adults
|
Phase 2 | |
Recruiting |
NCT04417582 -
Life Style Modification Medical and Surgical Management in Patients With Obesity
|
||
Recruiting |
NCT04924738 -
Female Obesity Cohort and Intervention Study Group (MOCART Study Group)
|
||
Completed |
NCT04305093 -
Data Mining: Precision Analytical Retrospective Data Correlation
|
||
Completed |
NCT04019860 -
Time-restricted Eating and High Intensity Interval Training Among Women
|
N/A |